You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 11, Issue 3

March 2019 - 162 articles

Cover Story: The increasing use of PD-1 inhibitors is causing immune-related adverse events that have never been observed with conventional chemotherapies. Their exact pathophysiology remains unclear, but their early recognition and treatment are crucial both for the resolution of symptoms and for treatment management. Immune-related neurological toxicities associated with PD-1 inhibitors are rarely reported, but as the use of these agents increases, it is important for clinicians to be aware of such serious potential side effects, which may have lasting consequences. Even if these side effects are rare and often respond well to steroid treatment, they can appear in different patterns and not always have a favorable outcome. Consultations with different specialists are necessary to classify and successfully treat these conditions, as many patients have a reasonable chance of long-term disease control. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (162)

  • Article
  • Open Access
44 Citations
16,687 Views
18 Pages

The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention

  • Ranjini Sankaranarayanan,
  • Chaitanya K. Valiveti,
  • D. Ramesh Kumar,
  • Severine Van slambrouck,
  • Siddharth S. Kesharwani,
  • Teresa Seefeldt,
  • Joy Scaria,
  • Hemachand Tummala and
  • G. Jayarama Bhat

26 March 2019

Flavonoids have emerged as promising compounds capable of preventing colorectal cancer (CRC) due to their anti-oxidant and anti-inflammatory properties. It is hypothesized that the metabolites of flavonoids are primarily responsible for the observed...

  • Article
  • Open Access
83 Citations
5,350 Views
11 Pages

A Pilot Clinical Study on the Prognostic Relevance of Plasmatic Exosomes Levels in Oral Squamous Cell Carcinoma Patients

  • Samuel Rodríguez Zorrilla,
  • Mario Pérez-Sayans,
  • Stefano Fais,
  • Mariantonia Logozzi,
  • Mercedes Gallas Torreira and
  • Abel García García

26 March 2019

Background: To evaluate the relationship between the plasmatic CD63 and CAV1 positive exosome levels, in patients with OSCC before and after surgical treatment and to correlate it with their overall survival. Methods: A double-blind pilot study over...

  • Review
  • Open Access
26 Citations
6,421 Views
21 Pages

An Insight into the Roles of MicroRNAs and Exosomes in Sarcoma

  • Isaku Kohama,
  • Nobuyoshi Kosaka,
  • Hirotaka Chikuda and
  • Takahiro Ochiya

26 March 2019

Sarcomas are rare solid tumors, but at least one-third of patients with sarcoma die from tumor-related disease. MicroRNA (miRNA) is a noncoding RNA that regulates gene expression in all cells and plays a key role in the progression of cancers. Recent...

  • Article
  • Open Access
47 Citations
4,514 Views
12 Pages

Store-Operated Calcium Entry Contributes to Cisplatin-Induced Cell Death in Non-Small Cell Lung Carcinoma

  • Roberta Gualdani,
  • Marie de Clippele,
  • Ikram Ratbi,
  • Philippe Gailly and
  • Nicolas Tajeddine

26 March 2019

Cisplatin (CDDP) is one of the principal chemotherapeutic agents used for the first-line treatment of many malignancies, including non-small cell lung carcinoma (NSCLC). Despite its use for over 40 years, its mechanism of action is not yet fully unde...

  • Article
  • Open Access
67 Citations
7,720 Views
10 Pages

Validation of miRNAs as Breast Cancer Biomarkers with a Machine Learning Approach

  • Oneeb Rehman,
  • Hanqi Zhuang,
  • Ali Muhamed Ali,
  • Ali Ibrahim and
  • Zhongwei Li

26 March 2019

Certain small noncoding microRNAs (miRNAs) are differentially expressed in normal tissues and cancers, which makes them great candidates for biomarkers for cancer. Previously, a selected subset of miRNAs has been experimentally verified to be linked...

  • Article
  • Open Access
11 Citations
3,365 Views
12 Pages

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin

  • Alexandre de Nonneville,
  • Dominique Barbolosi,
  • Maeva Andriantsoa,
  • Raouf El-Cheikh,
  • Florence Duffaud,
  • François Bertucci and
  • Sebastien Salas

26 March 2019

Introduction: Based on a mathematical model of trabectedin-induced neutropenia, we assessed the predictive value of absolute neutrophil count (ANC) on progression-free survival (PFS) in an independent validation cohort of patients treated with trabec...

  • Review
  • Open Access
11 Citations
3,812 Views
12 Pages

Novel Therapies and Approaches to Relapsed/Refractory HL Beyond Chemotherapy

  • Alain Antoine Mina,
  • Chetan Vakkalagadda and
  • Barbara Pro

25 March 2019

Although Hodgkin lymphoma (HL) is highly curable with first-line therapy, relapses occur in approximately 10–20% of patients with early stage disease and 30–40% of patients with advanced stage disease. The standard approach for relapsed o...

  • Article
  • Open Access
5 Citations
4,851 Views
15 Pages

A Simple and Highly Specific MassARRAY-Based Stool DNA Assay to Prioritize Follow-up Decisions in Fecal Immunochemical Test-Positive Individuals

  • Pi-Yueh Chang,
  • Chia-Chun Chen,
  • Jy-Ming Chiang,
  • Shih-Cheng Chang,
  • Mei-Chia Wang,
  • Jinn-Shiun Chen,
  • Wen-Sy Tsai,
  • Jeng Fu You and
  • Jang-Jih Lu

25 March 2019

Background: Seventy-five percent of fecal immunochemical test (FIT)-positive individuals are false positives and undergo unnecessary colonoscopies. Here, we established a stool DNA (sDNA) test that uses the Single Allele Base Extension Reaction (SABE...

  • Article
  • Open Access
32 Citations
3,813 Views
12 Pages

25 March 2019

Background: Neoadjuvant imatinib therapy has been proposed for routine practice with favorable long-term results for patients with locally advanced gastrointestinal stromal tumors (GISTs). However, clarification of the optimal duration, safety, and o...

  • Article
  • Open Access
10 Citations
3,869 Views
14 Pages

25 March 2019

The severity of liver fibrosis can be noninvasively evaluated by measuring liver stiffness (LS) using transient elastography. This study aimed to evaluate the prognostic value of achieving low liver stiffness measurement (LSM) in patients with cirrho...

of 17

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694